Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
ID: 349206Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Public and State Controlled Institutions of Higher Education

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349206

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-216.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers," aimed at enhancing research capacity in IDeA-eligible organizations. This grant is specifically designed for institutions that are current recipients of an active COBRE Phase 2 award, with the objective of transitioning established research programs and infrastructure towards independence and sustainability. The initiative is crucial for fostering biomedical research, particularly in historically underfunded areas, by providing support for administrative management, mentorship for early-stage investigators, and promoting diverse perspectives within research teams. Interested applicants can apply for a maximum budget of $750,000 in direct costs per year for up to five years, with applications due by September 30, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the detailed announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-216.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-216-Full-Announcement.html
    PAR-23-216.html
    The Department of Health and Human Services is offering a funding opportunity through the National Institutes of Health (NIH) titled "Limited Competition: Centers of Biomedical Research Excellence (COBRE) - Phase 3" aimed at enhancing research capacity in IDeA-eligible organizations. To qualify, institutions must be recipients of an active COBRE Phase 2 award. The purpose of Phase 3 funding is to solidify established research programs and infrastructure, ensuring sustainability beyond COBRE support. Key components include an Administrative Core responsible for overall management, a requirement for mentorship to early-stage investigators, and the promotion of diverse perspectives within research teams. The application must comply with strict guidelines, covering multiple aspects such as organizational goals, research accomplishments, and management strategies. A maximum budget of $750,000 in direct costs per year is available for up to five years. Each application undergoes scientific review, focusing on criteria including significance, innovation, and the capability of the principal investigator. The goal is to foster biomedical research and ensure continued development of research capacity in budget-constrained environments, particularly in historically underfunded areas. This initiative underscores the federal commitment to enhancing health research infrastructure regionally and nationally.
    Similar Opportunities
    Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Limited Competition Renewal of the Centers of Biomedical Research Excellence (COBRE) (Phase 2), aimed at enhancing biomedical research capacity at IDeA-eligible institutions. This program focuses on strengthening research infrastructure and developing investigators to secure independent research funding, extending support for an additional five years for established COBRE Phase 1 centers. Eligible institutions must demonstrate past successes under Phase 1, including publications and grant funding, and applications should include a multi-component structure with an Administrative Core and 2-5 Research Projects led by Early Stage or New Investigators. The total funding amount available is up to $1.5 million, with applications due by May 28, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-063.html.
    Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20) grants, aimed at enhancing biomedical research capacity at eligible institutions. The initiative seeks to establish thematic, multi-disciplinary centers that strengthen research infrastructure and support the development of investigators capable of competing for independent NIH research grants. This program is particularly significant for institutions in states with historically low success rates for NIH funding, as it aims to foster health-related research and improve competitiveness. Interested applicants can submit one application for funding, with a budget of up to $1.5 million annually for a maximum project period of five years, and must adhere to specific guidelines. The application deadline is January 30, 2025, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) program, aimed at enhancing the biomedical research capacity in IDeA-eligible states. This grant opportunity supports statewide networks of higher education and research institutions to foster faculty research, mentoring, and student involvement, with a focus on developing institutional infrastructure. The program allows for a maximum annual budget of $2.75 million over five years, requiring each application to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research. Interested applicants can find more information and submit proposals by the closing date of May 22, 2025, and should direct inquiries to grantsinfo@nih.gov.
    Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Biomedical Research Facilities (C06 Clinical Trial Not Allowed) grant, aimed at funding the construction or modernization of biomedical research facilities. This initiative seeks to enhance research infrastructure in academic and nonprofit institutions, particularly focusing on Institutions of Emerging Excellence (IEEs), with an emphasis on projects that support core facilities for broad biomedical research collaboration. Eligible applicants can request up to $8 million over five years, with a strong interest in projects that address women's health, emerging research methods, and increasing breeding capacity for specific nonhuman primates. Interested parties should submit their applications by January 27, 2025, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for revision applications from currently funded Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to enhance their support for outreach and research related to HIV and health disparities. The initiative aims to diversify and support the next generation of HIV/AIDS investigators by requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP), which will be a critical component of the application review process. This funding is vital for fostering innovative research and training programs that address key barriers in HIV research, particularly for underrepresented groups. The maximum award amount is $1.5 million annually, with applications due by October 9, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-080.html.
    Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Centers of Excellence in Genomic Science (CEGS) program, aimed at supporting innovative, interdisciplinary research in genomic science. This program seeks to establish academic centers that will develop transformative genomic approaches to address significant biomedical challenges, with a focus on integrating advanced technological and computational methods. Each award can provide up to $1.5 million per year for a maximum of five years, with potential renewal for an additional five years, and applications are due by June 23, 2025. Eligible applicants include a range of institutions such as higher education entities, nonprofits, and various government organizations, while foreign entities are not eligible. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) to enhance research on substance use, addiction, and HIV through collaborative efforts among investigators. This program aims to integrate diverse new and early career researchers, particularly from underrepresented backgrounds, to develop innovative approaches and interdisciplinary projects that transform the scientific research landscape. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and government entities, with a maximum project period of five years and a requirement to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested parties should note that the application deadline is November 17, 2025, and can find more information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA)," aimed at enhancing research capacity and technology innovation in biomedical engineering at HBCUs. This initiative seeks to bolster education and career development in biomedical engineering, with a phased funding approach allowing for up to $300,000 in direct costs for planning (UG3 Phase) and potentially up to $1,000,000 for full-scale program implementation (UH3 Phase). The program emphasizes the importance of diversity in the scientific workforce and aims to address health disparities through improved training and partnerships. Interested applicants must submit their proposals by September 30, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-25-002.html.
    NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NEI Center Core Grant for Vision Research, aimed at enhancing collaborative vision research through shared resource and service cores for funded investigators. This grant supports institutions with eight or more active NEI-supported R01 grants, providing direct costs of up to $2 million or $2.5 million over five years, depending on the number of eligible grants at the institution. The program is designed to increase productivity and collaboration among researchers while offering high-quality services that would be too costly for individual projects, ultimately supporting the NEI's mission to advance understanding of vision disorders. Applications are due by September 30, 2023, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.